Article Versions Notes

Fumagalli C, Tomao F, Betella I, Rappa A, Calvello M, Bonanni B, Bernard L, Peccatori F, Colombo N, Viale G, et al. Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy. Cancers. 2019; 11(11):1641. https://doi.org/10.3390/cancers11111641

Fumagalli, Caterina, Federica Tomao, Ilaria Betella, Alessandra Rappa, Mariarosaria Calvello, Bernardo Bonanni, Loris Bernard, Fedro Peccatori, Nicoletta Colombo, Giuseppe Viale, and et al. 2019. "Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy" Cancers 11, no. 11: 1641. https://doi.org/10.3390/cancers11111641

Fumagalli, C., Tomao, F., Betella, I., Rappa, A., Calvello, M., Bonanni, B., Bernard, L., Peccatori, F., Colombo, N., Viale, G., Barberis, M., & Guerini-Rocco, E. (2019). Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy. Cancers, 11(11), 1641. https://doi.org/10.3390/cancers11111641